12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Bristol-Myers, Otsuka Pharmaceutical sales and marketing update

The companies mutually decided that Otsuka will assume sales promotion and activities for Abilify aripiprazole in the U.S. Bristol will continue to co-promote neurology drug Abilify in Europe and be involved with manufacturing, distribution and pharmacovigilance activities related to Abilify globally....

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >